Skip to main content
SpringerLink
Log in

Atypical antipsychotics are an option for treating serious psychosis of Alzheimer’s disease, despite safety concerns and lack of evidence

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Madhusoodanan S, Shah P, Brenner R, et al. Pharmacological treatment of the psychosis of Alzheimer’s disease: what is the best approach? CNS Drugs 2007; 21(2): 101–15

    Article  PubMed  CAS  Google Scholar 

  2. Jeste D, Finkel S. Psychosis of Alzheimer’s disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8(1): 29–34

    Article  PubMed  CAS  Google Scholar 

  3. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293(5): 596–8

    Article  PubMed  CAS  Google Scholar 

  4. American Diabetic Association, American Psychiatric Association, American Association of Clinical Endocrinologists and North American Association for the study of obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetic Care 2004; 27(2): 596–601

    Article  Google Scholar 

  5. Grimmer T, Kurz A. Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer’s disease: a systematic review. Drugs Aging 2006; 23(12): 957–67

    Article  PubMed  CAS  Google Scholar 

  6. Gauthier S, Wirth Y, Möbius HJ. Effects of memantine on behavioral symptoms in Alzheimer’s disease patients: an analysis of neuropsychiatric inventory data of two randomized, controlled studies. Int J Geriatr Psychiatry 2005; 20(5): 459–64

    Article  PubMed  CAS  Google Scholar 

  7. Pollock BG, Mulsant BH, Rosen J, et al. Comparison of citalopram, perphenazine and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002; 159(3): 460–5

    Article  PubMed  Google Scholar 

  8. Stone M. Deaths in controlled trials of atypical antipsychotics in patients with behavioral disturbances from dementia. 45th Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting; 2005 Jun 6–9; Boca Raton (FL)

  9. US Food and Drug Administration. FDA public advisory: deaths with antipsychotics in elderly patients with behavioral disturbances [online]. Available from URL: http://www.fda.gov [Accessed 2007 Aug 13]

  10. Nelson JC. Increased risk of cerebrovascular adverse events and death in elderly demented patients treated with atypical antipsychotics: what’s a clinician to do? J Clin Psychiatry 2005; 66(8): 1071

    Article  PubMed  Google Scholar 

  11. Schneider LS, Pollack VE, Lyness SA. A meta analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990 (5); 38: 553–63

    PubMed  CAS  Google Scholar 

  12. Lanctôt KI, Best TS, Mittman N, et al. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry 1998; 59(10): 550–61 sai]13._Hermann N, Mamdani M, Lanct ot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161(6): 1113–5

    Article  PubMed  Google Scholar 

  13. Hermann N, Mamdani M, Lanctôt KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161 (6): 1113–5

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atypical antipsychotics are an option for treating serious psychosis of Alzheimer’s disease, despite safety concerns and lack of evidence. Drugs Ther. Perspect 23, 13–15 (2007). https://doi.org/10.2165/00042310-200723110-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200723110-00004

Search

Navigation